As of March 30, 2021 8:13 p.m.
According to a decision by the federal and state health ministers, the AstraZeneca vaccine should only be used for people aged 60 and over. The Standing Vaccination Commission had previously made a corresponding recommendation.
According to a decision by the federal and state health ministers, the AstraZeneca corona vaccine is only to be used for people aged 60 and over. Under 60-year-olds should be able to continue to be vaccinated with it “at the medical discretion and in the case of an individual risk analysis after careful explanation”, as can be seen from the decision that is available to the ARD capital studio.
The vaccine can now be used on all people over 60, regardless of their priority group: “The federal states are free to include 60 to 69 year-olds in their vaccination campaign for this vaccine,” it says.
The Federal Government’s Standing Vaccination Commission (STIKO) had previously changed its age recommendation for the vaccine. As the experts explained, this is done “on the basis of the currently available data on the occurrence of rare but very severe thromboembolic side effects” in younger people who have been vaccinated. Specifically, it concerns 31 cases of cerebral vein thrombosis that occurred in connection with vaccinations, mainly in women under 55.
AstraZeneca vaccine for the time being only for people aged 60 and over
Andreas König, ARD Berlin, daily news 8 p.m., March 30, 2021
Second dose with BioNTech?
The STIKO intends to make a supplementary recommendation by the end of April for the administration of the second dose to people under the age of 60 who have already received a first vaccination with AstraZeneca. Until then, studies should be evaluated as to whether a second vaccination is also possible with an mRNA vaccine such as from BioNTech.
The Erlangen virologist and STIKO member Klaus Überla described the decision against the editorial network Germany as correct. The available data suggest “a causal relationship between vaccination and the incidence of cerebral vein thrombosis in women – even if these are rare occurrences,” he said. At the same time, the risk of these women going through severe Covid 19 diseases must be considered. If they have no previous illnesses, it is moderate. “Overall, it would therefore be better to protect this group with other Covid-19 vaccines,” said Überla. In those over 60, however, “the Covid 19 risk far outweighs the risk of cerebral vein thrombosis”.
Armin Laschet, CDU, Prime Minister North Rhine-Westphalia, on the suspension of the AstraZeneca vaccine
Topics of the day 10:20 p.m., March 30, 2021
Previously, the federal states of North Rhine-Westphalia, Berlin and Brandenburg had temporarily suspended vaccinations with AstraZeneca for under 60-year-olds. The city of Munich also decided to stop. According to the Robert Koch Institute (RKI) vaccination rate monitoring system, around 2.7 million first doses and 767 second doses have been vaccinated by AstraZeneca so far.
Bund-Länder consultations in the evening
In the evening, Chancellor Angela Merkel and Health Minister Jens Spahn wanted to discuss how to deal with the vaccine with the Prime Ministers of the federal states. The Federal Press Office announced a press conference – following an “information meeting with the heads of government of the federal states on the further use of the AstraZeneca vaccine”.